Comparable stake leader
Dimitar Slavchev Savov
SEC ownership of NIKA PHARMACEUTICALS, INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001145604.
Disclosed value leader
Dimitar Slavchev Savov
Comparable rows
0/2
Latest evidence
18 Mar 2025
- Public ticker
- NIKA on OTC
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Dimitar Slavchev Savov
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
18 Mar 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001145604
- Issuer location
- Henderson, NV
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of NIKA PHARMACEUTICALS, INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Dimitar Slavchev Savov
Disclosed value leader
Dimitar Slavchev Savov
Comparable rows
0/2
Latest evidence
18 Mar 2025
3/4/5
Highest disclosed value: $113,897,375
2 rows are not safely comparable across share classes.
Quick read
Dimitar Slavchev Savov has the largest disclosed position value at $113.9M.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Dimitar Slavchev Savov's linked filing trail.
Disclosed position value
Top 1
Dimitar Slavchev Savov
$113.9M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Dimitar Slavchev Savov |
3/4/5
CEO, CFO, President, Director, 10%+ Owner
|
—
class O/S missing
|
$113,897,375
455,589,500 shares
|
— | 18 Mar 2025 |
| NIKA PHARMACEUTICALS, INC |
3/4/5
Secretary, Director, 10%+ Owner
|
—
class O/S missing
|
—
10,000,000 shares
|
— | 29 Apr 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-2 of 2 reporting-owner rows connected to NIKA PHARMACEUTICALS, INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
2
Largest Forms 3/4/5 holder
Dimitar Slavchev Savov
Net 12M change
$0
Latest report
18 Mar 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Dimitar Slavchev Savov | CEO, CFO, President, Director, 10%+ Owner | $113,897,375 | Filing P/S | 18 Mar 2025 | ||
| NIKA PHARMACEUTICALS, INC | Secretary, Director, 10%+ Owner | Mixed | 29 Apr 2022 |
Recent insider transactions for NIKA PHARMACEUTICALS, INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.